Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Empowering Young Minds: Sinhgad Schools Introduce India’s 1st Mental Health Education by The Mind Sync Education
  • Agarwal Industrial Corporation releases Q3 FY23 results – key highlights Business
  • BGMI Introduces New Redeem Codes in Latest Release on April 24 Lifestyle
  • Remedium Lifecare Posts Rs 4.64 Cr Q1 FY26 PAT, Over 2x FY25 Q1 Profit, Fuelling Growth & Expansion Plans Business
  • Vertex Global Services Expands Its Operations into Nepal Nepal is the fifth country where Vertex Global Services Operates English
  • Kaveesha Verma and Sushama win in Premium Beauty Pageant Glam Guidance Miss/Mrs India Universe 2022 in their categories Lifestyle
  • Bzinga to bring its first-ever Hindi show on Zee TV! Entertainment
  • Uphealth Provides End-to-end Medical Support To Patients to Ease Their Journeys towards Holistic Wellness Health

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Goodveda Health Labs Pvt Ltd makes grand debut in Indian market with health and wellness programs &supplements targeting diabetes and obesity Health
  • Webinar Organised On World Patient Safety Day to Discuss ‘Safe Maternal & Newborn Care’ Health
  • Maharashtra’s Trusted Gynecologist, Dr. Vidya Sangare, Honored for 17 Years of Outstanding Care and Over 1 Lakh Deliveries Health
  • Kosmoderma introduces cutting-edge technologies at their newest clinic launch in Mumbai Health
  • SSO Cancer Hospital Calls for Urgent Action on Lung Health This World Lung Day Health
  • Introducing MOI: India’s only Tens + Heating Device For Period Pain Health

Recent Posts

  • Zell Education Wins Prestigious Industry Award for Excellence in Finance Education
  • Meet Prague Film School: The Institution Betting That Access Beats Scale
  • Bharatiya Vyapar Mahotsav 2026: Ajmera Fashion Brings Surat’s Textile Industry to the National Stage
  • Aditya Kumar Halwasiya Acquires 6 Percent Stake In Baazar Style Retail Through Block Deal
  • Campus Shoes Announces ‘The Kids’ Constitution’ This Independence Day, Reimagining Freedom Through the Right to Play

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Healthroots: Health is wealth, an old saying but a perennial one Health
  • Big Boost for Para Sports: Yogesh Shelly Appointed Director of Para Athlete Development and Special Programs, India Para Powerlifting; Office Inaugurated by JP Singh and Satya Prakash Sangwan Lifestyle
  • Turn to Gold: Union MF Launches Dual NFOs Finance
  • Wonderchef leads the coffee revolution in India Business
  • Indore’s Dental Healthtech Startup, TeethFast, taking up Dental Industry by Storm Business
  • ABS Commences Charter Deployment of vessel “M.V. Ocean Diamond” for L&T Business
  • Mystery Rooms Launches Global Sensation ‘Prison Island’ in India Entertainment
  • A B Cotspin India Ltd Secures Significant Repeat Order Worth Rs. 5.35 Cr For 273 MT Cotton Yarn Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme